Related Experiment Video
Updated: Jul 2, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
[Registries for rare diseases. Compliance and data protection]
K Pommerening1, D Debling, P Kaatsch
1Institut für Medizinische Biometrie, Epidemiologie und Informatik der Johannes-Gutenberg-Universität Mainz. pommerening@imbei.uni-mainz.de
Rare disease research needs comprehensive data registries. Voluntary participation and informed consent, as shown by the German Childhood Cancer Registry, ensure data completeness for successful medical research.
Area of Science:
- Epidemiology
- Rare Diseases
- Medical Research
Context:
- Clinical and epidemiological research for rare diseases is challenged by small patient cohorts.
- Disease-specific networks are crucial for collecting comprehensive data.
- German Ministry of Research supports data collection initiatives.
Purpose:
- To highlight the importance of data registries for rare disease research.
- To demonstrate the feasibility of successful data collection through voluntary participation.
- To outline methods for establishing data registries and research networks compliant with data protection.
Summary:
- Comprehensive data collection in registries is essential for rare disease research.
- Voluntary participation based on informed consent yields satisfactory data completeness.
- The German Childhood Cancer Registry exemplifies successful data collection for medical research.
Impact:
- Enables robust clinical and epidemiological studies for rare diseases.
- Facilitates medical research by overcoming data scarcity.
- Provides a model for building compliant data registries and research networks.
Related Concept Videos
Purpose of Health Records II
Purpose of Health Records I
Here's a breakdown of how health records serve these purposes:
Legal Guidelines for Documentation
Types of Records II: Educational and Administrative Records
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials: Overview

